Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized double-blind, double dummy, placebo and lorazepam-controlled, 4-way cross-over study to evaluate the pharmacodynamics of single oral doses of BNC210 in healthy young male subjects.

Next Previous
Trial Profile

A randomized double-blind, double dummy, placebo and lorazepam-controlled, 4-way cross-over study to evaluate the pharmacodynamics of single oral doses of BNC210 in healthy young male subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jan 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BNC 210 (Primary) ; Lorazepam
  • Indications Anxiety disorders; Panic symptoms
  • Focus Pharmacodynamics

Most Recent Events

  • 01 Sep 2011 Results reported in a Bionomics media release, and to be presented at the European College of Neuropsychopharmacology (ECNP).
  • 30 Mar 2011 Positive results have been reported in a Bionomics media release; the company anticipates that data from this trial will be presented at a major scientific conference later this year.
  • 30 Mar 2011 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top